The summer of 2017 is the start of the golden age for cell immunotherapy. Since the end of June, there is no shortage of attention in this red-hot market. On June 29th, Sanpower Group, the Chinese pharma giant, has announced its acquisition of Dendreon with $819 million. The core product of the latter is the …
On September 21st, Zai Lab, the Chinese biopharma start-up, has officially listed in the United States Nasdaq global market, bagged a total of $150 million. On the same day, its stock rose 55.17%, amount to $27.93 per share. Zai Lab is not the first Chinese biopharmaceutical company which has completed an IPO in the United …
KingMed Diagnostics, Guangzhou based medical laboratory diagnostics giant, has officially listed in the Shanghai Stock Exchange on September 8th, marking the beginning of the Chinese third-party medical diagnostics industry holding hands with the capital market. KingMed Diagnostics, established in 2003, is an independent medical laboratory specializing in third-party medical testings and pathological diagnoses. Its main …